523 related articles for article (PubMed ID: 21515306)
21. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
22. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
[TBL] [Abstract][Full Text] [Related]
23. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
Kitai Y; Kondo T; Konishi E
J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
[TBL] [Abstract][Full Text] [Related]
24. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
Pugachev KV; Mason PW; Shope RE; Frey TK
Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
[TBL] [Abstract][Full Text] [Related]
25. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
[TBL] [Abstract][Full Text] [Related]
26. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
27. Flavivirus encephalitis: pathological aspects of mouse and other animal models.
Kimura T; Sasaki M; Okumura M; Kim E; Sawa H
Vet Pathol; 2010 Sep; 47(5):806-18. PubMed ID: 20551474
[TBL] [Abstract][Full Text] [Related]
28. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
[TBL] [Abstract][Full Text] [Related]
29. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
30. Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells?
Ren J; Ding T; Zhang W; Song J; Ma W
Virol J; 2007 Sep; 4():83. PubMed ID: 17803826
[TBL] [Abstract][Full Text] [Related]
31. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
[TBL] [Abstract][Full Text] [Related]
32. Cross-protection between West Nile and Japanese encephalitis viruses in red-winged blackbirds (Agelaius phoeniceus).
Nemeth NM; Bosco-Lauth AM; Bowen RA
Avian Dis; 2009 Sep; 53(3):421-5. PubMed ID: 19848083
[TBL] [Abstract][Full Text] [Related]
33. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
[TBL] [Abstract][Full Text] [Related]
34. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
[TBL] [Abstract][Full Text] [Related]
35. Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies.
Gangwar RS; Shil P; Cherian SS; Gore MM
Virus Res; 2011 Jun; 158(1-2):179-87. PubMed ID: 21477626
[TBL] [Abstract][Full Text] [Related]
36. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
37. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.
Ishikawa T; Widman DG; Bourne N; Konishi E; Mason PW
Vaccine; 2008 May; 26(22):2772-81. PubMed ID: 18433947
[TBL] [Abstract][Full Text] [Related]
38. Replicon-based Japanese encephalitis virus vaccines elicit immune response in mice.
Huang Y; Liu S; Yang P; Wang C; Du Y; Yu W; Sun Z
J Virol Methods; 2012 Jan; 179(1):217-25. PubMed ID: 22108431
[TBL] [Abstract][Full Text] [Related]
39. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
[TBL] [Abstract][Full Text] [Related]
40. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.
Yamshchikov G; Borisevich V; Kwok CW; Nistler R; Kohlmeier J; Seregin A; Chaporgina E; Benedict S; Yamshchikov V
Vaccine; 2005 Sep; 23(39):4785-92. PubMed ID: 15939510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
